These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 36991467)
1. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation. Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467 [TBL] [Abstract][Full Text] [Related]
2. ANXA2 as a novel substrate of FBXW7 promoting esophageal squamous cell carcinoma via ERK phosphorylation. Li Z; Pan Y; Yao J; Gao Y; Qian Y; Zheng M; Ma S Biochem Biophys Res Commun; 2023 Mar; 649():93-100. PubMed ID: 36758484 [TBL] [Abstract][Full Text] [Related]
3. FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells. Bi Y; Yang Y; Zhang Y; Cheng C; Tang P; Xiao H; Yuan F; Wu W; Yang B Neoplasma; 2023 Dec; 70(6):733-746. PubMed ID: 38014700 [TBL] [Abstract][Full Text] [Related]
4. Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma. Jiang YY; Shang L; Shi ZZ; Zhang TT; Ma S; Lu CC; Zhang Y; Hao JJ; Shi C; Shi F; Xu X; Cai Y; Jia XM; Zhan QM; Wang MR Oncogene; 2016 Sep; 35(37):4846-56. PubMed ID: 26876215 [TBL] [Abstract][Full Text] [Related]
5. miR-25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma. Hua Y; Zhao K; Tao G; Dai C; Su Y Oncol Rep; 2017 Nov; 38(5):3030-3038. PubMed ID: 29048664 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
7. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation. Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100 [TBL] [Abstract][Full Text] [Related]
9. circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion. Gu L; Sang Y; Nan X; Zheng Y; Liu F; Meng L; Sang M; Shan B Mol Cancer; 2022 Dec; 21(1):217. PubMed ID: 36514094 [TBL] [Abstract][Full Text] [Related]
10. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability. Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821 [TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway. Yu X; Huang M; Yang G Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577 [TBL] [Abstract][Full Text] [Related]
12. Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling. Wang J; Jia Q; Sun J; Wu S; Wei L; Yao W Cancer Biol Ther; 2024 Dec; 25(1):2408042. PubMed ID: 39341782 [TBL] [Abstract][Full Text] [Related]
13. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA. Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032 [TBL] [Abstract][Full Text] [Related]
15. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592 [TBL] [Abstract][Full Text] [Related]
16. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma. Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686 [TBL] [Abstract][Full Text] [Related]
17. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
18. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway. Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401 [TBL] [Abstract][Full Text] [Related]
19. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway. Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960 [TBL] [Abstract][Full Text] [Related]
20. NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143. Su W; Hu H; Ding Q; Wang M; Zhu Y; Zhang Z; Geng Z; Lin S; Zhou P Cell Commun Signal; 2022 Jun; 20(1):87. PubMed ID: 35705994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]